Mawad, Raya and Lionberger, Jack M and Pagel, John M (2013) Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Current hematologic malignancy reports, 8 (2). pp. 132-40. ISSN 1558-822X
Preview |
Text
MawadCurrentHematolMalignantRep.pdf - Accepted Version Download (167kB) | Preview |
Abstract
The incidence of acute myeloid leukemia (AML) is expected to increase in conjunction with our ageing population. Although it is proving to be a heterogeneous disease process, the only treatment with proven survival benefit for poor risk AML remains allogeneic hematopoietic cell transplant. Although this is presumed to be a curative strategy, many patients relapse after transplant, prompting us to examine various ways that we can improve outcomes. These efforts involve every step of AML diagnostics and therapy, including the intricate processes of conditioning, graft manipulation and immunomodulation. The hope is that improvement in these steps will ultimately improve survival and decrease relapse rates for AML patients after transplant.
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | The final publication is available at link.springer.com” |
| DOI: | 10.1007/s11899-013-0153-6 |
| PubMed ID: | 23456518 |
| NIHMSID: | NIHMS485118 |
| Grant Numbers: | P01 CA044991 |
| Fred Hutch Divisions: | Clinical Research |
| Depositing User: | Library Staff |
| Date Deposited: | 24 May 2013 20:08 |
| Last Modified: | 24 May 2013 20:08 |
| URI: | http://authors.fhcrc.org/id/eprint/610 |
Repository Administrators Only
 |
View Item |
